0001209191-14-075834.txt : 20141216 0001209191-14-075834.hdr.sgml : 20141216 20141216160633 ACCESSION NUMBER: 0001209191-14-075834 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141212 FILED AS OF DATE: 20141216 DATE AS OF CHANGE: 20141216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Connolly Thomas CENTRAL INDEX KEY: 0001453943 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 141289718 MAIL ADDRESS: STREET 1: 717 FIFTH AVENUE STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-12-12 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001453943 Connolly Thomas C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 SVP, Human Resources Common Stock 2014-12-12 4 S 0 300 119.73 D 34595 D Common Stock 2014-12-12 4 S 0 220 120.50 D 34375 D Common Stock 150 I 401(k) Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $119.73 (range $119.31 to $120.25). Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $120.50 (range $120.45 to $120.57). Kenneth L. Horton, Attorney-In-Fact 2014-12-16